Lipidomics/MS Core Manager

Job Locations US-NY-Valhalla
Requisition ID
Position Type
Schedule Shift
Hours Per Week
Basic Sciences & Institutional Effectiveness
FLSA Status


We are seeking a candidate to manage and perform analyses of lipid mediators from biological matrices using LC-MS/MS-based lipidomics and will be working primarily with a Shimadzu LC-8050 and an AB Sciex 3200 Qtrap system.  Position supports research work in several NYMC labs as well as outside vendor clients.


  • Independently prepare samples and independently run the biological samples on the LCMS/GCMS as well as data analysis.
  • Develop new methods and update/upgrade existing methods for quantitation and analyses and efficiently communicate and advise investigator.
  • Manage the daily operation and maintenance of the equipment and the Core.
  • Comply with general safety regulations, maintain lab equipment, order supplies, monitoring expenditures and maintain an accurate inventory.
  • Report problems in standardized procedures due to instrumental, sample or test system failures and identify potential hazards of the chemicals in use and adhere to the proper safety techniques.
  • Effectively communicate regarding data analyses and interpretation of data with investigators in NYMC labs and outside vendor clients (i.e. Regeneron, Biotech companies, etc.)


A) Education requirement:


At least a BS degree in chemistry/biochemistry and at least 3-5-years’ experience and knowledge of working in a core instrumentation laboratory.  Masters degree highly preferred


B) Technical/computer skills:


Some use of mass spectrometry technology; MS Outlook, Excel, PowerPoint, Word. Committed to using technology on behalf of Investigators.


C)Prior experience:


Experience with method development and analyses using chromatography and various chromatographic platforms (Shimadzu).  Experience with LC-MS/MS preferred.


Ability to work independently




Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed